Press releases
- Photocure Announces Mobile BLC Tower Initiative to Expand Access to Cysview in the U.S.
- Photocure ASA - Annual general meeting held
- Photocure ASA: Results for the first quarter of 2024
- Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Cevira in China
- Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detection with HD Technology Unveiled at AUA 2024
- Photocure ASA - Notice of the Annual General Meeting 23 May 2024
- Photocure ASA: Annual Report 2023
- European Association of Urology (EAU) 2024 congress features new data on modern technology use in bladder cancer care
- Photocure to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- New Publication: Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy
More ▼
Key statistics
On Friday, Photocure ASA (PHS:FRA) closed at 5.59, -8.81% below its 52-week high of 6.13, set on Jan 10, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.59 |
---|---|
High | 5.59 |
Low | 5.59 |
Bid | 5.59 |
Offer | 5.80 |
Previous close | 5.63 |
Average volume | 0.00 |
---|---|
Shares outstanding | 27.12m |
Free float | 26.68m |
P/E (TTM) | 383.59 |
Market cap | 1.83bn NOK |
EPS (TTM) | 0.1755 NOK |
Data delayed at least 15 minutes, as of Jun 07 2024 07:02 BST.
More ▼